“This transaction will allow Flora to immediately benefit from a profitable, cash flow positive and growing business,” said Luis Merchan, chairman and CEO of Flora Growth. “This strategic acquisition demonstrates our disciplined capital allocation approach that is consistent with both short-term needs and long-term vision as a leading global cannabis company. We look forward to increasing our product offering through this transaction while broadening our sales team in the process.”
The No Cap acquisition will fast-forward the introduction of high-quality flower and prerolls to Flora’s growing product portfolio and smokeables into JustBrand’s product portfolio. JustBrands will develop and further expand on their flower and smokable line as well as distribute the No Cap brand into Flora’s ~14,000 points of distribution.
The No Cap acquired assets are expected to add approximately 75 SKUs to Flora’s product portfolio, as well as the “No Cap” and “Moonblunt” trademarks. No Cap’s gas infusion technology should also complement Flora Labs’ manufacturing capabilities.
“No Cap’s unique product offering coupled with JustCBD’s robust distribution positions Flora to be the leader in the alternative cannabinoid segment,” Merchan added.
]]>